Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominantly inherited disorder of the fibrovascular
tissue. The most common symptoms are recurrent nose bleeds and multiple mucocutaneous telangiectases. Arteriovenous
malformations (AVMs) are less obvious. Because there is no permanent cure available, patients often suffer from mental
stress. Several studies have been performed to assess the quality of life (QoL) of HHT patients. These studies showed that
HHT patients rated bodily pain lower than the general population but altogether they had lower health-related QoL.